Skip to content

Using smart phone app to assess the correct usage of glaucoma drops

Smart Phone App Based Measurement of Short-Term Adherence to Anti Glaucoma Medications: A Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063013
Enrollment
186
Registered
2024-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Control Intervention1: Adherence to anti glaucoma drops when free sample is provided: Comparing the adherence to anti glaucoma medications, either Timolol maleate or Latanoprost once daily application

Sponsors

Aravind Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 years or more who are willing to participate 2.Newly diagnosed patients with open angle glaucoma (including primary open angle glaucoma, juvenile open angle glaucoma, pigmentary dispersion glaucoma, pseudoexfoliation glaucoma and normal tension glaucoma) 3.Initiated treatment with a once-daily dose of timolol or latanoprost alone, in both eyes 4.Readily access an Åndroid mobile operating system smartphone and internet service by either the patient or the patient’s caregiver 5.Have the ability to successfully self-administer a drop of IOP lowering medication or patients with a caregiver that can administer the drops for them

Exclusion criteria

Exclusion criteria: 1.Patients who are unable to obtain drops locally 2.Patients under monocular ocular hypotensive treatment 3.Patients with secondary glaucomas (all except Pigmentary and Pseudoexfoliation glaucoma) 4.Patients that require surgical intervention for glaucoma or other ocular disease 5.Patients with other ocular co-morbidities, which may need intervention for the same

Design outcomes

Primary

MeasureTime frame
To compare the adherence between the group which receives free drug sample and the group which buys the medications on there own for 60 days as measured by the smart phone app (as measured by the EyePhone© App)Timepoint: Adherence to AGM will be measured based on response to the phone app and questionnaire based survey at 2 months after which cross-over will be done between the groups and at 4th month the same will be repeated

Secondary

MeasureTime frame
-To evaluate various measures of adherence & identify barriers for good adherence (dosing errors, coverage, inter-dose interval, percent of doses taken) -Correlation between self-reported adherence via questionnaire vs. recorded live responses over time using the EyePhone app -Feasibility of using the EyePhone app for monitoring of patients in the south Indian population -The association between adherence on measured IOP Timepoint: 1.Baseline evaluation at the time of recruitment 2. At 2 months from recruitment 3. At 4 months from recruitment

Countries

India

Contacts

Public ContactUsha Tejaswini S

Aravind Eye Hospital, Pondicherry

drushatejaswini@gmail.com9916808738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026